9-halogen-(Z)-prostaglandin derivatives, process for their production and their use as pharmaceutical agents
US6225347A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Sep 27, 1994 |
| Grant date | May 1, 2001 |
| Priority date | — |
| Expiry date | Sep 27, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C405/0025
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention relates to 9-halogen-(Z) prostane derivatives of formula I ##STR1## in which ##STR2## PA0 Z represents the radicals PA0 Hal represents a chlorine or fluorine atom in the alpha or beta position, PA0 R.sub.1 represents the radical ##STR3## with R.sub.2 meaning a hydrogen atom, an alkyl, cycloalkyl, aryl or heterocyclic radical or R.sub.1 represents the radical ##STR4## with R.sub.3 meaning an acid radical or the radical R.sub.2 and PA0 A represents a --CH.sub.2 --CH.sub.2 --, a trans-CH.dbd.CH or --C.tbd.C group, PA0 W represents a free or a functionally modified ##STR5## group, and the respective OH groups can be in the alpha or beta position, PA0 D and E together represent a direct bond or PA0 D represents a straight-chain alkylene group with 1-10 C atoms, a branched-chain alkylene group with 2-10 C atoms or an annular alkylene group with 3-10 C atoms, which optionally can be substituted by fluorine atoms, and PA0 E represents an oxygen or sulfur atom, a direct bond, a C.tbd.C bond or a --CR.sub.6.dbd.CR.sub.7 group, and R.sub.6 and R.sub.7 are different and mean a hydrogen atom, a chlorine atom or a C.sub.1 -C.sub.4 alkyl group, PA0 R.sub.4 resents a free or function…
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.